Trending News

A study warns that rodent populations are developing genetic resistance to standard poisons. This shift complicates urban pest control and may force a rethink of current chemical-based strategies.

Medical research highlights why smell loss remains difficult to treat, emphasizing that while awareness has grown, diagnostic and recovery pathways for anosmia patients remain largely underdeveloped.

A surge in venture capital is driving a new gold rush in peptide manufacturing, as startups race to scale synthetic production despite significant regulatory and safety questions.

A new at-home diagnostic kit claims to identify Lyme disease pathogens in 15 minutes, but experts and testers are questioning its reliability compared to professional lab standards.

A newly engineered CRISPR enzyme is showing potential as a cancer-killing tool by directly shredding malignant DNA, though researchers warn of significant hurdles in safety and delivery.

Biotech deal-making is experiencing a resurgence not seen since 2019, as large pharmaceutical firms scramble to fill pipeline gaps through aggressive acquisitions.